The role of pharmacy in advancing evidence-based tobacco use treatment in the Veterans Health Administration

Clicks: 24
ID: 326574
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #86 of 259 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 259 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
PURPOSE: Pharmacy has been a key driver of enhanced patient access to tobacco use treatment in the Veterans Health Administration (VHA). The purpose of this article is to describe steps taken by VHA, particularly in integrating pharmacy expertise, to improve tobacco use treatment among veterans and their impact on pharmacotherapy prescribing. SUMMARY: Over the past 15 years, VHA policy has expanded patient access to tobacco use treatment medications and developed clinical practice models and training programs that integrate clinical pharmacist practitioners (CPPs) in the delivery of evidence-based tobacco use treatment. As a result of these policies and programs, prescribing of tobacco use treatment medications by CPPs increased almost 3-fold from 2014 to 2023 and over 50% of CPPs prescribe tobacco use treatment medications. CPPs accounted for approximately 30% of varenicline, nicotine nasal spray, and nicotine inhaler prescriptions in VHA in 2020, despite making up only 14% of all prescribers in VHA. CONCLUSION: With significant support from pharmacy providers, VHA has made great strides in increasing access to evidence-based care. The lessons learned from VHA may support other healthcare systems in increasing tobacco use treatment through use of pharmacy-led clinical programs.
Reference Key
openalex_W7204538497 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Timothy C. Chen, Mark C. Geraci, Mark G. Myers, Dana E. Christofferson, Jennifer Knoeppel, Michael Tran, Kim Hamlett-Berry, Pamela S. Belperio
Are you one of these authors? Claim your profile
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag248
URL
https://doi.org/10.1093/ajhp/zxag248
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.